JPMorgan Chase & Co. Purchases 370,511 Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL)
JPMorgan Chase & Co. raised its position in shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) by 75.7% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 859,710 shares of the company’s stock after purchasing an additional 370,511 shares during the quarter. JPMorgan […]
